Adapted Geriatric Vulnerability Score

Biomarker1 paper1 finding

Humans1

Effects

1

Overall survival

downin humans1HR 1.72

1 study

Adapted Geriatric Vulnerability Score decreases overall survival in humans (HR 1.72 (95% CI 1.20-2.47)).
HumansFIGO stage III-IV ovarian cancerfemalesn = 89
Assessing geriatric vulnerability in older women with advanced ovarian Cancer: Adapting the geriatric vulnerability score for routine clinical practice. The ELCAPA cohort study · Maturitas · 31 Aug 2026

Latest

1

MaturitasHumans7 Sep

Assessing geriatric vulnerability in older women with advanced ovarian Cancer: Adapting the geriatric vulnerability score for routine clinical practice. The ELCAPA cohort study